XCYTE Therapies, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for XCYTE Therapies, Inc..The latest application filed is for "compositions and methods for the treatment of burns and sepsis".

Company Profile

0.7.19

XCYTE Therapies, Inc. - Seattle WA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Compositions and methods for the treatment of burns and sepsis App 20060286089 - Berenson; Ronald J. ; et al.	2006-12-21
Activation and expansion of cells App 20060121005 - Berenson; Ronald J. ; et al.	2006-06-08
Depsipeptide and congeners thereof for use as immunosuppressants Grant 7,041,639 - Skov May 9, 2	2006-05-09
Compositions and methods for regulating lymphocyte activation App 20050261478 - Ledbetter, Jeffrey A. ; et al.	2005-11-24
T cell therapy for the treatment of cachexia and chronic diseases App 20050226857 - Bonyhadi, Mark ; et al.	2005-10-13
Activation and expansion of cells App 20050214942 - Berenson, Ronald ; et al.	2005-09-29
Depsipeptide and congeners thereof for use as immunosuppressants App 20050171011 - Skov, Soren	2005-08-04
Activation and expansion of cells App 20050153447 - Berenson, Ronald ; et al.	2005-07-14
Simultaneous stimulation and concentration of cells Grant 6,905,874 - Berenson , et al. June 14, 2	2005-06-14
Compositions and methods to accelerate hematologic recovery App 20050118173 - Berenson, Ronald J. ; et al.	2005-06-02
Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation App 20050084967 - Berenson, Ronald J. ; et al.	2005-04-21
Simultaneous stimulation and concentration of cells Grant 6,867,041 - Berenson , et al. March 15, 2	2005-03-15
Compositions and methods for regulating lymphocyte activation App 20040253250 - Ledbetter, Jeffrey A. ; et al.	2004-12-16
Therapeutic uses of depsipeptides and congeners thereof Grant 6,828,302 - Skov December 7, 2	2004-12-07
Activation and expansion of cells App 20040241162 - Berenson, Ronald J. ; et al.	2004-12-02
Generation and isolation of antigen-specific T cells App 20040224402 - Bonyhadi, Mark ; et al.	2004-11-11
Simultaneous stimulation and concentration of cells Grant 6,797,514 - Berenson , et al. September 28, 2	2004-09-28
Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation App 20040175373 - Berenson, Ronald ; et al.	2004-09-09
Compositions and methods for restoring immune repertoire in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation App 20040151704 - Berenson, Ronald ; et al.	2004-08-05
Compositions and methods for restoring immune responsiveness in patients with immunological defects App 20040005298 - Bonyhadi, Mark ; et al.	2004-01-08
Activation and expansion of cells App 20030235908 - Berenson, Ronald ; et al.	2003-12-25
Simultaneous stimulation and concentration of cells App 20030124122 - Berenson, Ronald ; et al.	2003-07-03
Activation and expansion of cells App 20030119185 - Berenson, Ronald ; et al.	2003-06-26
Maturation of antigen-presenting cells using activated T cells App 20030082806 - Berenson, Ronald Jay ; et al.	2003-05-01
Therapeutic uses of depsipeptides and congeners thereof Grant 6,548,479 - Skov April 15, 2	2003-04-15
Depsipeptide and congeners thereof for use as immunosuppressants Grant 6,403,555 - Skov June 11, 2	2002-06-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.